Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension

Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH sec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Douglas Mesadri Gewehr, Allan Fernando Giovanini, Beatriz Alvarez Mattar, Anelyse Pulner Agulham, Andressa de Souza Bertoldi, Seigo Nagashima, Fernando Bermudez Kubrusly, Luiz Fernando Kubrusly
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/93b96fa396814dabb356853deba43638
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:93b96fa396814dabb356853deba43638
record_format dspace
spelling oai:doaj.org-article:93b96fa396814dabb356853deba436382021-11-11T17:18:29ZCongestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension10.3390/ijms2221118911422-00671661-6596https://doaj.org/article/93b96fa396814dabb356853deba436382021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11891https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH secondary to right ventricular hypertrophy (RVH) related to monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH). Fifty male Wistar rats were divided into four groups and randomly assigned to control and experimental groups. Three experimental groups were submitted to intraperitoneal MCT inoculation (60 mg/kg) and were under its effect for 15, 30 and 37 days. The animals were then sacrificed, obtaining cardiac and hepatic tissues for anatomopathological and morphometric analysis. At macroscopic examination, the livers in the MCT groups presented a nutmeg-like appearance. PAH produced marked RVH and dilatation in the MCT groups, characterized by a significant increase in right ventricular free wall thickness (RVFWT) and chamber area. At histological evaluation, centrilobular congestion was the earliest manifestation, with preservation of the hepatocytes. Centrilobular hemorrhagic necrosis was observed in the groups exposed to prolonged MCT. Sinusoidal dilatation was markedly increased in the MCT groups, quantified by the Sinusoidal Lumen Ratio (SLR). The Congestive Hepatic Fibrosis Score and the Centrilobular Fibrosis Ratio (CFR) were also significantly increased in the MCT<sub>30</sub> group. Hepatic atrophy, steatosis, apoptotic bodies and, rarely, hydropic swelling were also observed. SLR correlated strongly with CFR and RVFWT, and CFR correlated moderately with RVFWT. Our rat model was able to cause CH, related to monocrotaline-induced PAH and RVH; it was feasible, reproducible, and safe.Douglas Mesadri GewehrAllan Fernando GiovaniniBeatriz Alvarez MattarAnelyse Pulner AgulhamAndressa de Souza BertoldiSeigo NagashimaFernando Bermudez KubruslyLuiz Fernando KubruslyMDPI AGarticleliver diseasecongestive hepatopathyhypertrophyright ventricularpulmonary arterial hypertensionmonocrotalineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11891, p 11891 (2021)
institution DOAJ
collection DOAJ
language EN
topic liver disease
congestive hepatopathy
hypertrophy
right ventricular
pulmonary arterial hypertension
monocrotaline
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle liver disease
congestive hepatopathy
hypertrophy
right ventricular
pulmonary arterial hypertension
monocrotaline
Biology (General)
QH301-705.5
Chemistry
QD1-999
Douglas Mesadri Gewehr
Allan Fernando Giovanini
Beatriz Alvarez Mattar
Anelyse Pulner Agulham
Andressa de Souza Bertoldi
Seigo Nagashima
Fernando Bermudez Kubrusly
Luiz Fernando Kubrusly
Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
description Heart dysfunction and liver disease often coexist. Among the types of cardiohepatic syndrome, Type 2 is characterized by the chronic impairment of cardiac function, leading to chronic liver injury, referred to as congestive hepatopathy (CH). In this study, we aimed to establish a rat model of CH secondary to right ventricular hypertrophy (RVH) related to monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH). Fifty male Wistar rats were divided into four groups and randomly assigned to control and experimental groups. Three experimental groups were submitted to intraperitoneal MCT inoculation (60 mg/kg) and were under its effect for 15, 30 and 37 days. The animals were then sacrificed, obtaining cardiac and hepatic tissues for anatomopathological and morphometric analysis. At macroscopic examination, the livers in the MCT groups presented a nutmeg-like appearance. PAH produced marked RVH and dilatation in the MCT groups, characterized by a significant increase in right ventricular free wall thickness (RVFWT) and chamber area. At histological evaluation, centrilobular congestion was the earliest manifestation, with preservation of the hepatocytes. Centrilobular hemorrhagic necrosis was observed in the groups exposed to prolonged MCT. Sinusoidal dilatation was markedly increased in the MCT groups, quantified by the Sinusoidal Lumen Ratio (SLR). The Congestive Hepatic Fibrosis Score and the Centrilobular Fibrosis Ratio (CFR) were also significantly increased in the MCT<sub>30</sub> group. Hepatic atrophy, steatosis, apoptotic bodies and, rarely, hydropic swelling were also observed. SLR correlated strongly with CFR and RVFWT, and CFR correlated moderately with RVFWT. Our rat model was able to cause CH, related to monocrotaline-induced PAH and RVH; it was feasible, reproducible, and safe.
format article
author Douglas Mesadri Gewehr
Allan Fernando Giovanini
Beatriz Alvarez Mattar
Anelyse Pulner Agulham
Andressa de Souza Bertoldi
Seigo Nagashima
Fernando Bermudez Kubrusly
Luiz Fernando Kubrusly
author_facet Douglas Mesadri Gewehr
Allan Fernando Giovanini
Beatriz Alvarez Mattar
Anelyse Pulner Agulham
Andressa de Souza Bertoldi
Seigo Nagashima
Fernando Bermudez Kubrusly
Luiz Fernando Kubrusly
author_sort Douglas Mesadri Gewehr
title Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
title_short Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
title_full Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
title_fullStr Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
title_full_unstemmed Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
title_sort congestive hepatopathy secondary to right ventricular hypertrophy related to monocrotaline-induced pulmonary arterial hypertension
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/93b96fa396814dabb356853deba43638
work_keys_str_mv AT douglasmesadrigewehr congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT allanfernandogiovanini congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT beatrizalvarezmattar congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT anelysepulneragulham congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT andressadesouzabertoldi congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT seigonagashima congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT fernandobermudezkubrusly congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
AT luizfernandokubrusly congestivehepatopathysecondarytorightventricularhypertrophyrelatedtomonocrotalineinducedpulmonaryarterialhypertension
_version_ 1718432132516282368